Physician

Andrew M Bernstein, D.O.

According to 2025 Medicare claims, Andrew Bernstein, D.O. (NPI: 1669490975) practices hematology/oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Passaic, NJ. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1801850243; TIN: 223141761) and primary practice location at 07457-0017.

Bernstein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 623 traditional Medicare patients, billed 195,891 HCPCS/CPT codes, and received $3,768,621 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 126 prescription claims across 63 beneficiaries totaling $43,731 in drug costs, led by Anastrozole (Anastrozole). DME data shows 62 claims. Open Payments data shows 9 records totaling $166. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,911,992 to $3,768,621. In contrast, Part D prescription costs have fallen sharply in recent years, from $352,741 to $43,731. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $10,160 and ending at $5,736.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	546	117,342	$1,911,992
2016	529	127,698	$2,246,771
2017	503	141,705	$2,153,367
2018	597	149,207	$2,428,687
2019	604	231,456	$3,988,268
2020	576	205,140	$4,229,537
2021	619	262,851	$4,218,048
2022	620	301,663	$4,972,422
2023	608	229,269	$4,257,306
2024	623	195,891	$3,768,621

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	147	506	$352,741
2016	175	692	$467,035
2017	202	757	$512,033
2018	249	1,145	$1,269,946
2019	320	1,517	$1,733,880
2020	319	1,618	$2,321,905
2021	318	1,293	$2,318,614
2022	78	167	$129,723
2023	55	116	$13,278
2024	63	126	$43,731

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	138	$9,822
2016	N/R	160	$9,331
2017	N/R	205	$8,877
2018	N/R	122	$4,967
2019	56	497	$21,018
2020	N/R	235	$10,058
2021	N/R	317	$13,256
2022	N/R	172	$8,661
2023	N/R	278	$15,129
2024	N/R	62	$3,031

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	541	1,448	$105
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	230	632	$75
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	302	741	$13
36415	Insertion of needle into vein for collection of blood sample	533	1,398	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	606	2,598	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Anastrozole	Anastrozole	33	2,054	$937
Warfarin Sodium	Warfarin Sodium	13	384	$220
Dexamethasone	Dexamethasone	11	361	$157

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	11	$2,030
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	17	$511
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	17	$249
J9190	Injection, fluorouracil, 500 mg	N	N/R	17	$241

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$166	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew M. Bernstein, D.O.?

Tedicare shows public-source Medicare data for Andrew M. Bernstein, D.O. (NPI 1669490975), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew M. Bernstein, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew M. Bernstein, D.O.?

Andrew M. Bernstein, D.O. is linked to REGIONAL CANCER CARE ASSOCIATES LLC (billing NPI 1801850243) in the available physician profile data.

Does Andrew M. Bernstein, D.O. have Open Payments data?

Andrew M. Bernstein, D.O. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.